Access S.P.I.R.I.T.: The Federal and Congressional Scoop on Research (May 2026)
References
- Rule: Medical Devices: General and Plastic Surgery Devices; Classification of the Phototherapy Device for Reducing the Appearance of Acute Post-Surgical Incisions (FDA Federal Register)
- Notice: List of Bulk Drug Substances for Which There Is a Clinical Need under the Federal Food, Drug, and Cosmetic Act (FDA Federal Register)
- Notice: Medical Devices: Exemptions from Premarket Notification: Certain Class II Devices (FDA Federal Register)
- Notice: Obesity and Drug Dosing: Clinical Pharmacology Considerations (FDA Federal Register)
- Notice: Request for Information: Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket (FDA Federal Register)
- FDA Approves First Non-Antipsychotic Drug to Treat Agitation Associated with Dementia (FDA Press Release)
- FDA Permits Expanded Access for Investigational Pancreatic Cancer Drug (FDA Press Release)
- Rule: Medical Devices: Immunology and Microbiology Devices; Classification of the Circulating Tumor Cell Enrichment Device (FDA Federal Register)
- Rule: Medical Devices: Immunology and Microbiology Devices; Classification of the Device to Preserve and Stabilize Relative Abundances of Microbial Nucleic Acids in Clinical Samples (FDA Federal Register)
- Rule: Medical Devices: Ophthalmic Devices; Classification of the Corneal Storage Medium With Preservatives Including Antifungals (FDA Federal Register)
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight (FDA Press Release)
- Chemistry, Manufacturing, and Controls Flexibilities for Developing Human Cellular and Gene Therapy Products for a Biologics License Application: Guidance for Industry (FDA Final Guidance Document)
- Notice: Guidance: Patient-Matched Guides for Orthopedic Implants (FDA Federal Register)
- Patient-Matched Guides for Orthopedic Implants: Guidance for Industry and Food and Drug Administration Staff (FDA Final Guidance Document)
- FDA Expands AI Capabilities and Completes Data Platform Consolidation (FDA Press Release)
- Rule: Medical Device: Obstetrical and Gynecological Devices; Classification of the External Condom for Anal Intercourse or Vaginal Intercourse (FDA Federal Register)
- Adding weekly GLP-1 to cognitive behavioral therapy further reduces heavy drinking (NIH Intramural News)
- New Video Overview for NIHโs Collaborative International Research Projects (PF5) (NIH Extramural News)
- Selecting the Right Models for Your Research: A Focus on New Approach Methodologies (NAMs) (NIH Extramural News)
- NIH-funded study suggests that testosterone suppresses brain tumor growth in males (NIH Intramural News)
- Oral small-molecule GLP-1 drugs penetrate deep into the brain to suppress cravings (NIH Intramural News)
- WTAS: FDA Announces Major Steps to Implement Real-Time Clinical Trials (HHS Press Release)
- Notice: Findings of Research Misconduct (HHS Federal Register)
- Research Misconduct Finding: Ariel Fernandez (HHS ORI Update)
- HHS Launches MAHA Action Plan to Curb Psychiatric Overprescribing (HHS Press Release)
- Proposed Rule: Modification of Certain Terminology (HHS Federal Register)
- ARPA-H Launches New Program to Deliver Rigorous, Gold-Standard Research Faster (HHS Press Release)
- Artificial Intelligence: Uses and Risks for Small Business Contracting and Innovation Research (GAO Report)
- M-26-13 Reopening the Department of Homeland Security (OMB Memoranda)
- Chairman Babin, Subcommittee Chairman Weber Applaud Committee Passage of National Quantum Initiative Reauthorization Act (House Committee on Space, Science, and Technology Press Release)
- Savings from Most-Favored-Nation Drug Pricing Policy (White House News)
- Notice: Guidance: Clostridioides difficile Infection: Developing Drugs for Treatment, Reduction of Recurrence, or Prevention (FDA Federal Register)
- Clostridioides difficile Infection: Developing Drugs for Treatment, Reduction of Recurrence, and Prevention (FDA Final Guidance Document)
- Notice: Guidance: Postapproval Pregnancy Safety Studies (FDA Federal Register)
- Postapproval Pregnancy Safety Studies (FDA Final Guidance Document)
- Notice: Guidance: Pulmonary Tuberculosis: Developing Drugs for Treatment (FDA Federal Register)
- Pulmonary Tuberculosis: Developing Drugs for Treatment (FDA Final Guidance Document)
- Rule: Nondiscrimination on the Basis of Disability; Accessibility of Web Content and Mobile Applications of Recipients of Departmental Financial Assistance; Extension of Compliance Dates (HHS Federal Register)
- Rule: Medical Devices: Immunology and Microbiology Devices; Classification of the Device to Detect and Identify Microorganism Nucleic Acids and Resistance Markers from Patients with Suspected Orthopedic Infection (FDA Federal Register)
- Notice: 21st Century Cures Act: Annual Compilation of Notices of Updates from the Susceptibility Test Interpretive Criteria Web Page (FDA Federal Register)
- Notice: Request for Information: Drug Repurposing for Unmet Medical Needs (FDA Federal Register)
- FDA Advances Drug Repurposing to Address Unmet Medical Needs (FDA Press Release)
- Rule: Restoring Flexibility in the Child Care and Development Fund (HHS Federal Register)
- Trump Administration Launches Moms.Gov for New and Expecting Mothers (HHS Press Release)
- President Trump Honors Americaโs Moms with New Support for Families (White House News)
- HHS Supports Repatriation of U.S. Citizens to Specialized Care Facilities (HHS Press Release)
- FDA Grants Seventh Approval under the National Priority Voucher Pilot Program (FDA Press Release)
- Consolidate Your eRA Commons Accounts with New Feature (NIH Extramural News)
- An Update on How NIH Protects NIH-Funded Research from Undue Foreign Interference (NIH Extramural News)
- Researchers develop innovative model for risk assessment for hypertrophic cardiomyopathy (NIH Intramural News)
- NIH-funded study maps human pancreatic islet cells, offering new clues to diabetes risk (NIH Intramural News)
- Notice: Request for Information: Azodicarbonamide (ADA) (FDA Federal Register)
- Notice: Request for Information: Butylated hydroxytoluene (BHT) (FDA Federal Register)
- FDA Finalizes Food Chemical Safety Post-Market Assessment Program, Launches Reassessment of BHT, ADA (FDA Press Release)
- Notice: Request for Information: Biomarker Incubator: Urinary Kidney Safety Biomarkers (FDA Federal Register)
- Proposed Rule: Excepted Fertility Benefits (HHS Federal Register)
- HHS Announces Heartland Forward MOU to Advance Maternal Health (HHS Press Release)
- (GENERAL-26-27) Technology Security Alert โ Ongoing Cybersecurity Incident Involving the Canvas Learning Management System (Federal Student Aid Announcement)
- What to know after the Canvas cyberattack (FTC Consumer Alert)
- Chairman Cassidy, Tuberville Seek Answers on Canvas Cybersecurity Incident, Calls for More Safeguards to Protect Students (SENATE Help Committee Press Release)
- Notice: Delegation of Authority: Agency for Healthcare Research and Quality (HHS Federal Register)
- SAMHSA Awards $255 Million to Administer 988 Lifeline (HHS Press Release)
- ORI is Currently Reviewing 2026 Co-sponsorship Expressions of Interest (ORI Update)
- NIH-supported project expands access to care for children with amblyopia (NIH Intramural News)
- Helpful Reminders to Ensure Integrity of NIH-Supported Research When Using Artificial Intelligence (NIH Extramural News)
- Chairmen Cassidy, Walberg, Moolenaar, Banks Sound Alarm on Chinese Communist Party Infiltrating American Universities, Threatening National Security (Senate HELP Committee Press Release)
- HHS Announces Restructuring of its Office for Civil Rights (HHS Press Release)
- Secretary Kennedy Brings โTake Back Your Healthโ Tour to California, Highlights Microbiome Research and Addiction Recovery (HHS Press Release)
- Fact Sheet: President Donald J. Trump Announces Expansion of TrumpRx.gov to Bring Americans Transparency and Choice on Everyday Medicines (White House News)
- Rule: Patient Protection and Affordable Care Act: HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program (HHS Federal Register)
- Notice: Requirements and Registration for `EHIgnite Challengeโ (HHS Federal Register)
- HHS, USDA Announce Investments to Expand Protein Access, Strengthen Cold Chain Infrastructure (HHS Press Release)
- Telecommunications: Selected Agencies Have Taken Steps to Address Risks of Equipment Linked to China (GAO Report)
- Science & Tech Spotlight: Privacy Enhancing Technologies (GAO Report)
- HHS Launches Phase 1 of the Cultivating Connected Communities Challenge (HHS Press Release)
- Secretary Kennedy Announces HHS Action to Reduce Harmful Screen Use and Protect Children Online (HHS Press Release)
- Reinforcing NIHโs Continued Commitment to Fundamental Research (NIH Extramural News)
- Artificial Intelligence: A Framework to Assess U.S. Competitiveness and Inform Policy Options (GAO Report)
- Privacy and Cybersecurity: VA Has Made Progress Enhancing Security Controls for Protected Health Information (GAO Report)
- Federal Research: Agencies Should Better Manage Anticipated Publishing Cost Increases Amid Shift to Public Access (GAO Report)
- Notice: Guidance: M11 Clinical Electronic Structured Harmonised Protocol; International Council for Harmonisation (FDA Federal Register)
- M11 Clinical Electronic Structured Harmonised Protocol (FDA Final Guidance Document)
- HHS Cracks Down on Years of Unchecked Audit Findings (HHS Press Release)
- FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection (FDA Press Release)
- Assessing the Effects of Food on Drugs in INDs and NDAs โ Clinical Pharmacology Considerations (FDA Final Guidance Document)
- NIH researchers identify avenue for enhanced GLP-1-induced weight loss (NIH Intramural News)
- Implementing SimplerNOFO at NIH: A Clearer, Simpler Path for Applicants (NIH Extramural News)
- Looking for Animal Welfare Content? OLAW has moved to NIH Grants and Funding! (NIH Extramural News)
- M-26-14 Ensuring Effective and Efficient Agency Logging and Network Visibility to Defend Against Evolving Cyber Threats (OMB Memoranda)
- Rule: Medical Device: Gastroenterology-Urology Devices; Classification of the Endoscopic Suturing Device for Altering Gastric Anatomy for Weight Loss (FDA Federal Register)
- Notice: Request for Information: AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program (FDA Federal Register)
- NOT-OD-26-084: Reminder โ Definition of Foreign Components (NIH Policy Notice)
- FY25 Enrollment Data from NIH-Supported Clinical Research Now Available (NIH Extramural News)
- Rule: Medical Devices: Neurological Devices; Classification of the Transcutaneous Electrical Nerve Stimulator to Treat Fibromyalgia Symptoms (FDA Federal Register)
- Notice: Guidance: Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted under an Abbreviated New Drug Application (FDA Federal Register)
- Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an Abbreviated New Drug Application (FDA Final Guidance)
- Notice: Guidance: Content of Human Factors Information in Medical Device Marketing Submissions (FDA Federal Register)
- Content of Human Factors Information in Medical Device Marketing Submissions: Guidance for Industry and Food and Drug Administration Staff (FDA Final Guidance)
- Notice: Guidance: Statistical Approaches to Establishing Bioequivalence (FDA Federal Register)
- Statistical Approaches to Establishing Bioequivalence (FDA Final Guidance)
- Proposed Rule: Regulation for Federal Financial Assistance (HHS Federal Register)
- New Guidance Documents Available (ORI Update)










